Skip to main content
Contact Us
Subscribe
E-Edition
74°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about REGN
Recent news which mentions REGN
< Previous
1
2
...
17
18
19
20
21
22
23
24
25
...
27
28
Next >
Viatris Just Snagged a Major FDA Approval
March 03, 2022
Tickers
ABBV
NVS
REGN
RHHBY
Tags
RHHBY
VTRS
Market News
From
Motley Fool
Is Intellia a Good Gene-Editing Stock to Buy Now?
March 03, 2022
Tickers
NTLA
REGN
Tags
REGN
Market News
NTLA
From
Motley Fool
The Daily Biotech Pulse: Legend Biotech, CTI Biopharma Receive FDA Approvals, AbbVie Announces Delay In Skyrizi Review, Editas Gains On CRISPR Patent Resolution
March 01, 2022
Tickers
ABBV
AMRN
AMRS
AVID
Tags
IBB
HRTX
VALN
From
Benzinga
Intellia Shares Updated Data On Gene Editing Durability In Rare Disease
March 01, 2022
Tickers
NTLA
REGN
Tags
Benzinga
Biotech
Movers
From
Benzinga
Does the FDA Rollback Of Regeneron And Eli Lilly COVID Treatment EUAs Signal A Need To Look Beyond Monoclonal Antibodies? NanoViricides, Inc. Looks To Meet This Need With A New Approach
February 28, 2022
Tickers
GSK
LLY
NNVC
REGN
Tags
VIR
NanoViricides
Market News
From
Benzinga
3 Moonshot Stocks Insiders Are Buying. What Do They Know?
February 25, 2022
Tickers
CLOV
CRL
CSII
FFIE
Tags
MTTR
NOTV
SPAK
From
InvestorPlace
7 Low Volatility Stocks to Buy Right Now for Steady Returns
February 24, 2022
Tickers
BRK-B
GRMN
INFY
KO
Tags
NOC
BRK/B
TXN
From
InvestorPlace
Why Kodiak Sciences Stock Is Cratering Today
February 23, 2022
Tickers
KOD
REGN
Tags
Market News
Recent Press Releases
REGN
From
Motley Fool
KOD Stock Alert: Why Is Kodiak Sciences Plunging 80% Today?
February 23, 2022
Tickers
KOD
REGN
Tags
Market News
Today's Market
REGN
From
InvestorPlace
Palo Alto Is Leading the Nasdaq Higher, but 1 Biotech Is Getting Crushed Wednesday
February 23, 2022
Tickers
KOD
PANW
REGN
Tags
^IXIC
KOD
REGN
From
Motley Fool
Why Kodiak Sciences Shares Are Plunging Today
February 23, 2022
Tickers
KOD
REGN
Tags
News
Health Care
Trading Ideas
From
Benzinga
Is Moderna the Next Gilead or the Next Regeneron?
February 22, 2022
Tickers
GILD
MRK
MRNA
REGN
Tags
MRK
Hot Stocks
Market News
From
InvestorPlace
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
Tickers
ABCL
AGIO
ARNA
ATXI
Tags
GKOS
Earnings
PEN
From
Benzinga
The Daily Biotech Pulse: Regeneron-Sanofi Halt Late-Stage Dupixent Study, Agios Gets FDA Nod, Safety Scare For GSK's RSV Vaccine, Shockwave Jumps On Earnings
February 18, 2022
Tickers
AGIO
AZN
BMY
GMED
Tags
Biotech
Benzinga
REGN
From
Benzinga
Sanofi-Regeneron's Dupixent Falls Short In Chronic Spontaneous Urticaria Trial
February 18, 2022
Tickers
ANY
NVS
REGN
RHHBF
Tags
Benzinga
Phase 3 Trial
Biotech
From
Benzinga
3 Top Biotech Stocks to Buy for the Long Haul
February 17, 2022
Tickers
MRNA
REGN
VRTX
Tags
MRNA
VRTX
Market News
From
Motley Fool
5 Value Stocks To Watch In The Healthcare Sector
February 14, 2022
Tickers
FONR
QURE
REGN
SURF
Tags
QURE
FONR
Market News
From
Benzinga
Lilly's Antibody Receives FDA Emergency Use Nod For Mild-To-Moderate COVID-19
February 14, 2022
Tickers
ABCL
LLY
REGN
Tags
General
FDA
ABCL
From
Benzinga
3 Biotech Stocks That Are too Cheap to Ignore
February 10, 2022
Tickers
GSK
ICPT
LLY
REGN
Tags
VKTX
VIR
Market News
From
Motley Fool
Alnylam Clocks 76% Increase In Q4 Product Sales, Expects FY22 Product Sales Of Up To $1B
February 10, 2022
Tickers
ALNY
NVS
REGN
Tags
REGN
Briefs
Benzinga
From
Benzinga
Sanofi - Regeneron's Dupixent Under FDA Priority Review For Children Under 5 Years With Atopic Dermatitis
February 10, 2022
Tickers
REGN
SNY
Tags
Market News
General
FDA
From
Benzinga
The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly
February 10, 2022
Tickers
AGLE
ALNY
ALVR
ARMP
Tags
Offerings
VKTX
AZN
From
Benzinga
10 Biggest Price Target Changes For Tuesday
February 08, 2022
Tickers
CRNC
DDOG
MCK
REGN
Tags
Price Target
Health Care Distributors
REGN
From
Benzinga
‘You will not believe what I’ve just found.’ Inside the ivermectin saga: a hacked password, mysterious websites and faulty data
February 07, 2022
Tickers
GILD
GSK
LLY
MRK
Tags
PFE
REGN
GSK
From
MarketWatch
Cathie Wood's Ark Invest Sheds Stake In This Large-Cap Pharma Ahead Of Earnings
February 05, 2022
Tickers
ARKG
BNTX
MRK
PFE
Tags
Cathie Wood
BNTX
Market News
From
Benzinga
Could This New Indication Create a Blockbuster for Pfizer?
February 05, 2022
Tickers
ABBV
PFE
REGN
SNY
Tags
Market News
REGN
SNY
From
Motley Fool
This Will Put a Big Dent in Eli Lilly's and Regeneron's Sales This Year
February 04, 2022
Tickers
LLY
PFE
REGN
Tags
LLY
Market News
Recent Press Releases
From
Motley Fool
COVID-19 treatments raked in billions of dollars in 2021. How will they do this year?
February 04, 2022
Tickers
GILD
GSK
LLY
MRK
Tags
PFE
REGN
GSK
From
MarketWatch
Regeneron's Q4 Sales, Profits More Than Double With Boost From COVID-19 Treatment Sales
February 04, 2022
Tickers
REGN
Tags
General
Market News
Briefs
From
Benzinga
The Daily Biotech Pulse: Sanofi, Bristol-Myers Squibb Gain On Earnings, Valneva-Pfizer Tout Positive Lyme Disease Vaccine Data, UNITY Biotech Restructures
February 04, 2022
Tickers
AKRO
BMY
GLPG
IBB
Tags
UBX
IBB
GLPG
From
Benzinga
< Previous
1
2
...
17
18
19
20
21
22
23
24
25
...
27
28
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.